26
Annexure ‘C’ to the Directors’ Report
Business Responsibility Report
(Pursuant to Clause 55 of Listing Agreements entered into with the Stock Exchanges)
About our report:
GSK, a science-led global healthcare company makes innovative products that are used by millions
of people around the world. The products we develop and manufacture and the way we do this
contributes directly to the health and well being of patients and consumers, and indirectly to society
and the economy. The Company’s mission drives us to make a real difference to the lives of millions
of people with our commitment to effective healthcare solutions.
Nurturing people and planet is key to the success of a corporation. At GSK, we look at
practices that incorporate sustainability into the core of our business to make innovative products.
Business responsibility is about our commitment to be open and transparent about our business
activities.
Our Business Responsibility Report follows the Securities and Exchange Board of India’s (SEBI)
proposal and is in accordance with the key principles enunciated in the ‘National Voluntary Guidelines
on Social, Environmental and Economic Responsibilities of Business’.
In this report, we provide details of the Company in the areas of sustainability, human rights, stakeholder
engagement, employees’ wellbeing, corporate social responsibility, proactive advocacy and inclusive
growth.
Governance and Accountability:
Our commitment to responsible, values-based business underlies everything we do including how we
conduct and report our sales and marketing practices. We are building a strong values-based culture.
Our actions are backed by robust policies and strong compliance process.
We conduct our business in an ethical way. Our policies on ethics, bribery and corruption cover all our
Stakeholders like suppliers, vendors, contractors, NGOs, etc.
Being a part of the global corporation, we have a common Code of Conduct across the globe. This
code sets out fundamental standards for all employees. It is supported by the Employees Guide
to Business Conduct, which helps employees take ethical decisions and emphasises our values:
transparency, respect for people, integrity, and focusing on the patient. Every employee at the time
of induction is taken through the code of business conduct and specialised training is provided for
employees working in manufacturing, sales and marketing, where there are additional requirements.
In addition, all managers and employees are required to confirm their compliance with the code on
an annual basis.
We market our prescription medicines and vaccines to healthcare professionals, hospitals and
government. Our policies and updated Global Code of Practice for Promotion and Customer Interactions
prescribe the nature of our practises and prohibits specifically those which are unethical. This code
as the name suggests is applicable worldwide. Our regional and local policies, standard operating
procedures and other codes provide additional guidance to employees. Additionally, we are signatory
to the OPPI (Organisation of Pharmaceuticals Producers in India) code of marketing conduct. This is
available online on their site
/
.
A strong grievance redressal body and supportive ecosystems ensure sufficient mechanism to enable
a culture of disclosure. In addition, specific process and mechanisms to facilitate reporting of unethical
conduct or violation of laid down guidelines as well as for protection of employees that report unethical
conduct are in place.
Sustainable products and services:
Brand GSK through its products and services touches the lives of millions of patients every day. To
protect the interest of our patients, we aim to work with responsible suppliers who meet the same
quality, social and environmental standards as GSK and its affiliates worldwide.
For us the interest of patients comes first at every stage from development until the final distribution.
Being a global company, GSK’s most products are approved by major international regulators like
USFDA, UKMHRA. This is apart from the mandatory regulatory approvals required in India endorsing
the safety of the product.
1...,20,21,22,23,24,25,26,27,28,29 31,32,33,34,35,36,37,38,39,40,...102